Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05738005 · ClinicalTrials.gov registry record · NA
Dietary Reporting in the Amyloidoses
A NA study of Amyloidosis, sponsored by Barbara Ann Karmanos Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT05738005 is a NA study of Amyloidosis that is actively recruiting participants, run by Barbara Ann Karmanos Cancer Institute. The registered enrollment target is 40 participants, below the 1,127-participant average among 28 other Amyloidosis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05738005, a NA study of Amyloidosis, is actively recruiting participants, sponsored by Barbara Ann Karmanos Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis. The main question it aims to answer is: Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amyloidosis patients Participants will be asked to: * Download the MyFitnessPal application on their smartphone and view an online tutorial * After a week of practice, from weeks 2-9, participants will enter daily dietary intake as well as daily herbal/alternative supplement intake into the MyFitnessPal application on their smartphone. * complete a questionnaire prior to starting the application, after week 2 and at week 10 after starting the application
Conditions Studied
Interventions
- OTHER Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app)
Study Locations (1)
Michigan
- Karmanos Cancer Institute - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2023-03-02 |
| Est. Completion | 2025-11-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05738005
The ClinicalTrials.gov registry entry for NCT05738005 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,127-participant average among 28 other Amyloidosis trials with a reported enrollment target (96% lower). The listed sponsor is Barbara Ann Karmanos Cancer Institute, which has 139 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Amyloidosis appearing as the primary indexed condition, and to 1 intervention - of which Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app) is the first listed.
NCT05738005 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT05738005 about?
NCT05738005 is a clinical study titled "Dietary Reporting in the Amyloidoses". The goal of this clinical trial is to learn about malnutrition and weight loss in patients with Amyloidosis. The main question it aims to answer is: Is it feasible to use a low-cost nutrition-based application (apps) for use on a smartphone to obtain detailed information on caloric intake in Amylo...
What is the current status of trial NCT05738005?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2023-03-02. Estimated completion is 2025-11-21.
What conditions does trial NCT05738005 study?
This clinical trial studies the following conditions: Amyloidosis.
What interventions are being tested in trial NCT05738005?
The interventions under investigation include: Tracking Dietary/Supplement Intake on MyFitnessPal smartphone application (app) (OTHER).
Who is sponsoring clinical trial NCT05738005?
This trial is sponsored by Barbara Ann Karmanos Cancer Institute, which has 139 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05738005 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyloidosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF
RECRUITING · NA
-
Clinical Trial to Assess the Safety of a Novel Scaffold Biomaterial
ACTIVE NOT RECRUITING · NA
-
Bortezomib/Dexamethasone (BD), Followed By Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone For the Initial Treatment of Monoclonal Immunoglobulin Deposition Disease (MIDD) Associated With Multiple Myeloma and AL Amyloidosis
COMPLETED · NA
-
Characterizing Iodine-124 Evuzumitide (AT-01) in Systemic Amyloidosis
RECRUITING · Phase 2
-
Cancer and Aging Resilience Evaluation in Older Adults With Hematologic Malignancies: The CARE-Heme Registry
RECRUITING
-
A Study Of Myocardial Stiffness In Amyloidosis With Magnetic Resonance Elastography
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.